Investor Relations

INVESTORS & MEDIA

INVESTORS
& MEDIA

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.

In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.

 

NASDAQ REGN

$391.59 3.10 (0.79)%

High 396.36 Low 390.52 Volume 669,073 Market Cap 41.32B
11/17/17 4:00 PM ET | Minimum 20 minutes delay.

Stock information provided by eSignal.

Financial information

NEWSROOM

  • Nov 15

    Regeneron Announces Upcoming Investor Conference Presentation

    Read on
  • Nov 08

    Regeneron Reports Third Quarter 2017 Financial and Operating Results

    Read on

EVENTS

  • 29th Annual Piper Jaffray Healthcare Conference
    Nov 28, 2017 | 4:00 PM ET

Events & Presentations

NASDAQ REGN

$391.59 3.10 (0.79)%

High 396.36 Low 390.52 Volume 669,073 Market Cap 41.32B
11/17/17 4:00 PM ET | Minimum 20 minutes delay.

Stock information provided by eSignal.

Stock information

Financial information